154 related articles for article (PubMed ID: 36881267)
21. Inferior vena cava assessment can predict contrast-induced nephropathy in patients undergoing cardiac catheterization: A single-center prospective study.
Gungoren F; Besli F; Tanriverdi Z; Demirbag R
Echocardiography; 2018 Dec; 35(12):1915-1921. PubMed ID: 30303247
[TBL] [Abstract][Full Text] [Related]
22. Intravenous Fluid Therapy Is Associated with a Reduced Incidence of Contrast-Induced Nephropathy but not with a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization.
Bottinor W; Chawla R; Danyi P; Patel K; Turlington J; Sangal K; Hong W; Perera RA; Jovin IS
Cardiovasc Revasc Med; 2020 Jan; 21(1):20-23. PubMed ID: 31378387
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
Zhang X; Yang S; Zhang P; Fu N
Coron Artery Dis; 2020 May; 31(3):284-288. PubMed ID: 31658134
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Webb JG; Pate GE; Humphries KH; Buller CE; Shalansky S; Al Shamari A; Sutander A; Williams T; Fox RS; Levin A
Am Heart J; 2004 Sep; 148(3):422-9. PubMed ID: 15389228
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
Kaya A; Kurt M; Tanboğa IH; Işik T; Ekinci M; Aksakal E; Kaya Y; Topçu S; Sevimli S
Acta Cardiol; 2013 Oct; 68(5):489-94. PubMed ID: 24283110
[TBL] [Abstract][Full Text] [Related]
26. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
27. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization.
Capodanno D; Ministeri M; Dipasqua F; Dalessandro V; Cumbo S; Gargiulo G; Tamburino C
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):524-9. PubMed ID: 25304032
[TBL] [Abstract][Full Text] [Related]
28. Preventive Effects of Nicorandil and Atorvastatin in Contrastinduced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Artery Angiography: A Double Blind, Randomized, Controlled Clinical Trial.
Mohammadi Kebar S; Atighi E; Hosseninia S; Babapour B
Iran J Kidney Dis; 2023 Jul; 17(4):205-214. PubMed ID: 37634247
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Induced Nephropathy After Cardiac Catheterization: Culprits, Consequences and Predictors.
Sedhai YR; Golamari R; Timalsina S; Basnyat S; Koirala A; Asija A; Choksi T; Kushwah A; Geovorgyan D; Dar T; Borikar M; Ahangar W; Alukal J; Zia S; Missri J
Am J Med Sci; 2017 Nov; 354(5):462-466. PubMed ID: 29173356
[TBL] [Abstract][Full Text] [Related]
30. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
31. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.
Yi B; Mo S; Jiang Y; Yi D; Luo J; Chen X; Rong J
J Interv Cardiol; 2020; 2020():4527816. PubMed ID: 32982608
[TBL] [Abstract][Full Text] [Related]
33. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
34. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.
Gomes VO; Lasevitch R; Lima VC; Brito FS; Perez-Alva JC; Moulin B; Arruda A; Oliveira D; Caramori P
Arq Bras Cardiol; 2012 Dec; 99(6):1129-34. PubMed ID: 23184077
[TBL] [Abstract][Full Text] [Related]
35. Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients.
Gao YM; Li D; Cheng H; Chen YP
Clin Exp Nephrol; 2014 Dec; 18(6):892-8. PubMed ID: 24515307
[TBL] [Abstract][Full Text] [Related]
36. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
37. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
39. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
40. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
